Search

Author/Creator Kawada, Junji

1. 330. RANDOMIZED PHASE II STUDY OF DOCETAXEL VERSUS PACLITAXEL IN PATIENTS WITH ESOPHAGEAL SCC REFRACTORY TO FLUOROPYRIMIDINE- AND PLATINUM-BASED CHEMOTHERAPY: OGSG1201. (24th September 2022)

Authors:
Matsuyama, Jin; Yamamoto, Sachiko; Kii, Takayuki; Hara, Hiroki; Kawabata, Ryohei; Kawada, Junji; Takeno, Atsushi; Ueda, Shugo; Kawakami, Hisato; Okita, Yoshihiro; Endo, Shunji; Kimura, Yutaka; Yanagihara, Kazuhiro; Okuno, Tatsuya; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh
Journal:
Diseases of the esophagus
Issue:
Volume 35(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II). (September 2018)

Authors:
Nishikawa, Kazuhiro; Tsuburaya, Akira; Yoshikawa, Takaki; Kobayashi, Michiya; Kawada, Junji; Fukushima, Ryoji; Matsui, Takanori; Tanabe, Kazuaki; Yamaguchi, Kazuya; Yoshino, Shigefumi; Takahashi, Masazumi; Hirabayashi, Naoki; Sato, Seiji; Nemoto, Hiroshi; Rino, Yasushi; Nakajima, Junta; Aoyama, T...
Journal:
European journal of cancer
Issue:
Volume 101(2018)
Page Start:
220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108). Issue 6 (16th July 2021)

Authors:
Imamura, Hiroshi; Matsuyama, Jin; Nishikawa, Kazuhiro; Endo, Shunji; Kawase, Tomono; Kimura, Yutaka; Fukui, Junichi; Kawada, Junji; Kurokawa, Yukinori; Fujitani, Kazumasa; Sakai, Daisuke; Kawakami, Hisato; Tsujinaka, Toshimasa; Shimokawa, Toshio; Matsubara, Yoshihiro; Satoh, Taroh; Furukawa, Hiroshi
Journal:
Annals of gastroenterological surgery
Issue:
Volume 5:Issue 6(2021)
Page Start:
776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. (September 2021)

Authors:
Yamamoto, Sachiko; Kawakami, Hisato; Kii, Takayuki; Hara, Hiroki; Kawabata, Ryohei; Kawada, Junji; Takeno, Atsushi; Matsuyama, Jin; Ueda, Shugo; Okita, Yoshihiro; Endo, Shunji; Kimura, Yutaka; Yanagihara, Kazuhiro; Okuno, Tatsuya; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh
Journal:
European journal of cancer
Issue:
Volume 154(2021)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial. (16th August 2018)

Authors:
Kawakami, Hisato; Takeno, Atsushi; Endo, Shunji; Makari, Yoichi; Kawada, Junji; Taniguchi, Hirokazu; Tamura, Shigeyuki; Sugimoto, Naotoshi; Kimura, Yutaka; Tamura, Takao; Fujitani, Kazumasa; Sakai, Daisuke; Shimokawa, Toshio; Kurokawa, Yukinori; Satoh, Taroh
Journal:
Oncologist
Issue:
Volume 23:Number 12(2018)
Page Start:
1411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗